More on CELG

- Summary
- Chart
- Profile
- Historical


- Earnings (+12.2% Growth)
- Ratings (7.3 Score)
- Holders
- Event Driven Deals


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (7/28/16)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

CELG Income Statement

Click line-items for a historical chart and %
Net product sales 2.49B
Collaborative agreements and other revenue 16.9M
Royalty revenue
Total revenue 2.51B
Cost of goods sold (excluding amortization of acquired intangible assets)
Research and development 733.2M
Selling, general and administrative 543M
Amortization of acquired intangible assets
Acquisition related (gains) charges and restructuring, net 36.2M
Total costs and expenses 1.51B
Operating income 1B
Other income and expense:
Interest and investment income, net 6.8M
Equity in (gains) losses of affiliated companies
Interest expense -121.9M
Other income, net 35.2M
Income before income taxes 921.6M
Income tax provision 120.9M
Net income 800.7M
Less: Net loss attributable to non-controlling interest
Net income attributable to Celgene
Net income per share attributable to Celgene:
Basic 1.03
Diluted 0.99
Weighted average shares:
Basic 780.6M
Diluted 807.7M